Cargando…
Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants
The ubiquitin proteasome system (UPS) has garnered much attention due to its potential for the development of therapeutics. Following a successful clinical application of general proteasome inhibitors much effort has been devoted to targeting individual UPS components including E3 enzymes and deubiq...
Autores principales: | Gorelik, Maryna, Sidhu, Sachdev S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434665/ https://www.ncbi.nlm.nih.gov/pubmed/28580429 http://dx.doi.org/10.1002/btm2.10044 |
Ejemplares similares
-
Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer
por: Shiromizu, Takashi, et al.
Publicado: (2020) -
The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy
por: Wang, Xuemei, et al.
Publicado: (2023) -
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
por: Wang, Maoyu, et al.
Publicado: (2023) -
Interplay between bacterial deubiquitinase and ubiquitin E3 ligase regulates ubiquitin dynamics on Legionella phagosomes
por: Liu, Shuxin, et al.
Publicado: (2020) -
The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?
por: Zou, Min, et al.
Publicado: (2021)